Lantheus hires former Bayer director as new CMO

By staff writers

January 13, 2020 -- Lantheus Medical Imaging parent company Lantheus Holdings has named Dr. Istvan Molnar as the company's new chief medical officer (CMO).

Molnar is an oncologist who practiced medicine as an internist for three years and was an assistant professor at Wake Forest University School of Medicine. He has 12 years of experience in the pharmaceutical industry and the development of oncology drugs, including a tenure as deputy of global medical affairs for the healthcare division of contrast developer Bayer. Most recently, Molnar served as chief medical officer of biopharmaceutical company Fusion Pharmaceuticals.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking